Clinical Trial Update: Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pazopanib as frontline therapy for non-resectable or metastatic soft tissue sarcoma patients who are not candidates for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma Soft Tissue
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Sarcoma, Soft Tissue, Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2020-06-09